2022
DOI: 10.3390/ph15121514
|View full text |Cite
|
Sign up to set email alerts
|

Vulvodynia: Pain Management Strategies

Abstract: Background: Vulvodynia is defined in this international consensus as persistent vulvar pain that occurs for >3 months without an identifiable cause and with several potential associated factors. At present there is no univocal consensus in the therapeutic treatment of vulvodynia. The methods of intervention are based on various aspects including, above all, the management of painful symptoms. Methods: a research on scientific database such as “Pubmed”, “Medline Plus”, “Medscape” was conducted, using the wor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 57 publications
0
1
0
Order By: Relevance
“…Regarding the therapeutic approach of vulvodynia, a stepwise method of pelvic floor dysfunction treatment, adequate psychological support, and sexual healthcare is recommended along with medical therapies [35]. Intermittent use of topical lidocaine cream may be useful for women with intense vestibular touch pain, prior to sexual intercourse [36].…”
Section: Vulvodyniamentioning
confidence: 99%
“…Regarding the therapeutic approach of vulvodynia, a stepwise method of pelvic floor dysfunction treatment, adequate psychological support, and sexual healthcare is recommended along with medical therapies [35]. Intermittent use of topical lidocaine cream may be useful for women with intense vestibular touch pain, prior to sexual intercourse [36].…”
Section: Vulvodyniamentioning
confidence: 99%
“…The International Society for the Study of Vulvovaginal Diseases defines localized provoked vulvodynia (LPV) as vulvar pain lasting at least 3 months without readily detectable accompanying inflammation or infection ( Bornstein et al., 2016 ). While LPV affects 8-28% of cis-gender, female-identifying individuals during their lifetime ( Reed et al., 2004 ; Reed et al., 2012 ; Harlow et al., 2014 ), it is frequently misdiagnosed and lacks effective therapeutic approaches ( Merlino et al., 2022 ). However, self-reported history of allergies to pollen and insect venom, and recurrent vulvovaginal yeast infections are both associated with an increased incidence of vulvodynia ( Sarma et al., 1999 ; Witkin et al., 2002 ; Harlow et al., 2009 ; Marfatia et al., 2016 ; Harlow et al., 2023 ) suggesting that immune mechanisms may be involved in its underlying pathophysiology.…”
Section: Introductionmentioning
confidence: 99%